Welcome to Francis Academic Press

International Journal of Frontiers in Sociology, 2025, 7(1); doi: 10.25236/IJFS.2025.070103.

Research on drug patent linkage system

Author(s)

Wang Ya

Corresponding Author:
Wang Ya
Affiliation(s)

Law School, CJLU University, Hangzhou, China

Abstract

This paper first summarizes the development process and main contents of China's drug patent linkage system, including the patent information registration and publicity system, the simplified application system for generic drugs, the patent exemption system and the monopoly period system for the first generic drug market. Subsequently, this paper analyzes the shortcomings of the system, such as the optimization of the drug patent registration platform, the reasonable setting of the waiting period, and the dispute resolution mechanism of the dual-track administrative and judicial system. Finally, this paper puts forward some suggestions for improving the drug patent linkage system in China, including improving the information registration and publicity platform, standardizing the application procedures for drug patent declarations, and reasonably setting the waiting period for chemical drugs.

Keywords

drug patent linkage system, generic drugs, patent information registration, dispute resolution mechanism

Cite This Paper

Wang Ya. Research on drug patent linkage system. International Journal of Frontiers in Sociology (2025), Vol. 7, Issue 1: 12-18. https://doi.org/10.25236/IJFS.2025.070103.

References

[1] BO Yuhong. Analysis of the Fourth Amendment to China's Patent Law. Electronic Intellectual Property, 2021, (03). 

[2] CAO Hongying. SONG Beibei. WANG Zhichao. An International Comparative Study on the Early Resolution Mechanism of Drug Patent Disputes. Electronic Intellectual Property Rights, 2021, (09). 

[3] DU Chengjie. On the Implementation and Improvement of the Drug Patent Linkage System in China: From the Perspective of American Practice. Southwest Intellectual Property Review, 2020, (02): 101-123.

[4] GENG Lidong. LIU Nancen. Traceability of Drug Patent Linkage System. China Science and Technology Information, 2021, (23). 

[5] Geng Wenjun. Important Factors Affecting the Drug Patent Linkage System and the Solution Path. Intellectual Property Rights, 2018, (07). 

[6] GUAN Chunyuan. International Development and Local Improvement of Drug Patent Linkage System. China Inventions & Patents, 2021, (06). 

[7] LIANG Zhiwen. Transplantation and Creation of Drug Patent Linkage System. Politics and Law, 2017,(8). 

[8] TAN Yuexiang. The Basis of Labor Theory of Value in Institutional Analysis. Hunan Social Sciences, 2017,(4). 

[9] WU Kewei. Definition and Attribute Analysis of Generic Drug Patent Challenge Behavior -- Based on the Localization of Drug Patent Link System. Electronic Intellectual Property, 2019(10). 

[10] Meng Bayi. Tough Regulation Makes a Strong Industry – A 110-Year Snapshot of FDA Drug Regulation. China Food and Drug Administration, 2018, (6). 

[11] WEI Cong. TIAN Tian. DU Guoshun. Institutional Design of Early Resolution Mechanism for Patent Disputes of Drugs with Chinese Characteristics: From the Perspective of Comparison between Foreign Experience and Domestic Status. China Journal of New Drugs, 2021, (30). 

[12] ZENG Li, FU Xuemin. Practical Problems and Solutions of Drug Patent Linking System in China. Chinese Invention and Patent, 2019,(16).

[13] LU Keyu. Research on the strategy of coping with the evergreen of drug patents in China. China Inventions and Patents, 2022, (6).